Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Ferrari

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Journal of Medicinal Chemistry|December 4, 2010
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductaseStefania Ferrari, Federica Morandi, Domantas Motiejunas, et al.
American Journal of Perinatology|June 26, 2019
Pregnancy after Endometriosis: Maternal and Neonatal Outcomes according to the Location of the DiseaseStefano Uccella, Paolo Manzoni, Antonella Cromi, et al.
Current Medicinal Chemistry|October 20, 2015
Current and Future Chemotherapy for Chagas DiseaseLuís Gaspar, Carolina B Moraes, Lucio H Freitas-Junior, et al.
Journal of Medicinal Chemistry|September 6, 2012
Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitorsPaola Corona, Federica Gibellini, Andrea Cavalli, et al.
HIV Medicine|July 2, 2025
Anal cancer screening in a cohort of women with HIV: Uptake and outcomes from a prospective study in Northern ItalyMaria Mazzitelli, Davide Leoni, Egidio Campagnolo, et al.
Journal of Medicinal Chemistry|March 12, 2021
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface TargetingGaetano Marverti, Chiara Marraccini, Andrea Martello, et al.
Cancers|January 21, 2023
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian CarcinomaDomenico D'Arca, Leda Severi, Stefania Ferrari, et al.
Frontiers in Pharmacology|June 6, 2018
Proteomic and Bioinformatic Studies for the Characterization of Response to Pemetrexed in Platinum Drug Resistant Ovarian CancerLeda Severi, Lorena Losi, Sergio Fonda, et al.
Journal of Medicinal Chemistry|July 24, 2018
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell GrowthPuneet Saxena, Leda Severi, Matteo Santucci, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2011
Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthaseDaniela Cardinale, Giambattista Guaitoli, Donatella Tondi, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|December 4, 2010
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductaseStefania Ferrari, Federica Morandi, Domantas Motiejunas, et al.
American Journal of Perinatology|June 26, 2019
Pregnancy after Endometriosis: Maternal and Neonatal Outcomes according to the Location of the DiseaseStefano Uccella, Paolo Manzoni, Antonella Cromi, et al.
Current Medicinal Chemistry|October 20, 2015
Current and Future Chemotherapy for Chagas DiseaseLuís Gaspar, Carolina B Moraes, Lucio H Freitas-Junior, et al.
Journal of Medicinal Chemistry|September 6, 2012
Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitorsPaola Corona, Federica Gibellini, Andrea Cavalli, et al.
HIV Medicine|July 2, 2025
Anal cancer screening in a cohort of women with HIV: Uptake and outcomes from a prospective study in Northern ItalyMaria Mazzitelli, Davide Leoni, Egidio Campagnolo, et al.
Journal of Medicinal Chemistry|March 12, 2021
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface TargetingGaetano Marverti, Chiara Marraccini, Andrea Martello, et al.
Cancers|January 21, 2023
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian CarcinomaDomenico D'Arca, Leda Severi, Stefania Ferrari, et al.
Frontiers in Pharmacology|June 6, 2018
Proteomic and Bioinformatic Studies for the Characterization of Response to Pemetrexed in Platinum Drug Resistant Ovarian CancerLeda Severi, Lorena Losi, Sergio Fonda, et al.
Journal of Medicinal Chemistry|July 24, 2018
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell GrowthPuneet Saxena, Leda Severi, Matteo Santucci, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2011
Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthaseDaniela Cardinale, Giambattista Guaitoli, Donatella Tondi, et al.
Pageof 13